CELSIUS HOLDINGS ($CELH) posted quarterly earnings results for Q4 2025 on Thursday, February 26th. The company reported earnings of $0.26 per share, beating estimates of $0.21 by $0.05. The company also reported revenue of $721,630,000, beating estimates of $653,650,629 by $67,979,371.
You can see Quiver Quantitative's $CELH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CELSIUS HOLDINGS Insider Trading Activity
CELSIUS HOLDINGS insiders have traded $CELH stock on the open market 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CELH stock by insiders over the last 6 months:
- WILLIAM H. MILMOE sold 40,000 shares for an estimated $2,500,000
- PAUL H. STOREY (Chief Supply Chain Officer) sold 7,500 shares for an estimated $456,975
- HAL KRAVITZ purchased 10,000 shares for an estimated $452,400
- JARROD LANGHANS (Chief Financial Officer) sold 5,000 shares for an estimated $325,000
- ERIC HANSON (President & COO) purchased 4,558 shares for an estimated $200,232
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CELSIUS HOLDINGS Hedge Fund Activity
We have seen 328 institutional investors add shares of CELSIUS HOLDINGS stock to their portfolio, and 364 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,450,365 shares (-75.2%) from their portfolio in Q4 2025, for an estimated $157,819,695
- NORGES BANK added 2,792,518 shares (+977.0%) to their portfolio in Q4 2025, for an estimated $127,729,773
- TWO SIGMA INVESTMENTS, LP removed 2,627,894 shares (-85.4%) from their portfolio in Q4 2025, for an estimated $120,199,871
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 2,521,231 shares (+inf%) to their portfolio in Q4 2025, for an estimated $115,321,105
- ALLIANCEBERNSTEIN L.P. added 2,480,726 shares (+15.4%) to their portfolio in Q4 2025, for an estimated $113,468,407
- CAPITAL INTERNATIONAL INVESTORS removed 2,052,003 shares (-65.6%) from their portfolio in Q4 2025, for an estimated $93,858,617
- STEADFAST CAPITAL MANAGEMENT LP removed 2,016,688 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $115,939,393
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CELSIUS HOLDINGS Analyst Ratings
Wall Street analysts have issued reports on $CELH in the last several months. We have seen 13 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 01/29/2026
- Needham issued a "Buy" rating on 01/07/2026
- B of A Securities issued a "Underperform" rating on 12/19/2025
- Piper Sandler issued a "Overweight" rating on 12/17/2025
- Stifel issued a "Buy" rating on 11/07/2025
- Citigroup issued a "Buy" rating on 11/07/2025
- UBS issued a "Buy" rating on 11/07/2025
To track analyst ratings and price targets for CELSIUS HOLDINGS, check out Quiver Quantitative's $CELH forecast page.
CELSIUS HOLDINGS Price Targets
Multiple analysts have issued price targets for $CELH recently. We have seen 14 analysts offer price targets for $CELH in the last 6 months, with a median target of $70.0.
Here are some recent targets:
- Michael Lavery from Piper Sandler set a target price of $65.0 on 01/29/2026
- Andrea Teixeira from JP Morgan set a target price of $77.0 on 01/29/2026
- Peter Grom from UBS set a target price of $70.0 on 01/14/2026
- Gerald Pascarelli from Needham set a target price of $70.0 on 01/07/2026
- Jonathan Keypour from B of A Securities set a target price of $45.0 on 12/19/2025
- Filippo Falorni from Citigroup set a target price of $65.0 on 11/07/2025
- Matthew Smith from Stifel set a target price of $60.0 on 11/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.